Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
The summary for the Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons: The purpose of this FOA is to support up to 24 state and local health departments in the United States to implement PrEP (Category 1) and Data to Care (Category 2) demonstration projects prioritizing populations of MSM and transgender persons who have sex with men. Organizations that are funded under this FOA will be required to prioritize their services to these populations. Services may also be provided for persons at substantial risk for HIV (for PrEP) or persons who have HIV and are not virally suppressed or have ongoing risk behavior (for Data to Care) who are not MSM or transgender.
|Federal Grant Title:||Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons|
|Federal Agency Name:||Centers for Disease Control and Prevention|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||CDC-RFA-PS15-1506|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||HIV Prevention Activities_Health Department Based|
|Current Application Deadline:||Jun 1, 2015 Electronically submitted applications|
|Original Application Deadline:||Jun 1, 2015 Electronically submitted applications|
|Posted Date:||Mar 31, 2015|
|Creation Date:||Mar 31, 2015|
|Archive Date:||Jul 1, 2015|
|Total Program Funding:||$50,000,000|
|Maximum Federal Grant Award:||$7,000,000|
|Minimum Federal Grant Award:||$500,000|
|Expected Number of Awards:||24|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- County governments
City or township governments
- Additional Information on Eligibility
- Eligibility for Category 1 (PrEP Support Demonstration Projects Targeting MSM and Transgender Persons at Substantial Risk of Acquiring HIV) is limited to health departments whose jurisdiction includes one or more of the thirty two (32) MSAs/MDs in which there are greater than 3,000 MSM living with diagnosed HIV by year-end 2010 (2011 MSA report, table 6b, published Oct 2013).
For the purposes of this FOA, definitions for the following terms apply:
Metropolitan Statistical Area (MSA): MSA are geographic entities defined by the U.S. Office of Management and Budget (OMB) for use by Federal statistical agencies in collecting, tabulating and publishing Federal statistics. Furthermore, the underlying concept of a MSA is that of a core area containing a large population nucleus, together with adjacent communities having a high degree of economic and social integration with that core. MSA are composed of entire counties or county equivalents. Every MSA has at least one urbanized area with a population of 50,000 or more.
Metropolitan Division: A metropolitan division (MD) is used to refer to a county or group of counties within a Metropolitan Statistical Area that has a population core of at least 2.5 million. (http://www.whitehouse.gov/omb/assets/bulletins/b10-02.pdf )
Eligibility for Category 2 (Data to Care Demonstration Projects That Use Surveillance Data Sources to Identify MSM and Transgender Persons Not in HIV Care) is limited to health departments that are eligible to apply for Category 1 and have complete reporting of all CD4 cell count and HIV viral load results.
Complete laboratory reporting of CD4 and HIV viral load test results is defined as follows:
The jurisdiction’s laws/regulations require the reporting of all CD4 and viral load results to the state/city health department
A minimum of 95% of HIV-related test results from laboratories that perform HIV-related testing for each area are being reported to the state/city health department
The jurisdiction is reporting at least 95% of all CD4 and viral load test results to CDC as of January 2014 (as outlined in the 2012 Monitoring Report, published in November 2014).
- Link to Full Grant Announcement
- Grant Announcement Contact
- Carolyn Leighton
Centers for Disease Control and Prevention 770-488-2756
- Similar Government Grants
- • Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the U...
- • Secure Data Sharing Tool to Support De-duplication of Cases in the National HIV Surveillan...
- • Integrated HIV Surveillance and Prevention Programs for Health Departments
- • Use of molecular HIV surveillance to identify active HIV transmission networks and impleme...
- • Secretarys Minority AIDS Initiative Funding for
- • Rapid Test Algorithms for Diagnosis of HIV Infection and Improved Linkage to Care
- • Expanded and Integrated Human Immunodeficiency Virus (HIV) Testing for Populations Disprop...
- • National HIV Behavioral Surveillance System (U62)
- More Grants from the Centers for Disease Control and Prevention
- • 93.067
- • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
- • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
- • Strengthening Ebola rapid detection and response capacity through community based surveill...
- • test2